en · de · es · fr · pt
analytical-notes.peptides9002.com › Wiki › Chemistry And Receptor Pharmacology — Questions and Answers

Chemistry And Receptor Pharmacology — Questions and Answers

By Editorial Desk · published 2026-01-05 · last reviewed 2026-01-27 · Wiki

afamelanotide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-01-27. Numbers and descriptions here follow the published literature rather than marketing material.

Chemistry and Receptor Pharmacology

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Peptide Identity and Structural Background

Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.

Melanotan-2 at a glance

PropertyValueNotes
Molecular formulaC50H69N15O9Cyclic heptapeptide, C-terminally amidated
Approximate molecular mass1024 DaMonoisotopic mass of the free peptide
AppearanceWhite to off-white powderTypically supplied as a lyophilised solid
Solubility classSoluble in water and polar solventsAlso dissolves in neutral aqueous buffer
Common synonymsMelanotan II, MT-II, MT-2Described as a melanocortin agonist in early literature

Melanotan-2 Identity and Receptor Pharmacology

Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.

Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.

Related pages on this site

Background and Receptor Mechanism

Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.

Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.

Further detail

=== Composition === The Composition C-4 used by the United States Armed Forces contains 91% RDX ("Research Department Explosive", an explosive nitroamine), bound by a mixture of 5.3% dioctyl sebacate (DOS) or dioctyl adipate (DOA) as the plasticizer (to increase the plasticity of the explosive), thickened with 2.1% polyisobutylene (PIB, a synthetic rubber) as the binder, and 1.6% of a mineral oil often called "process oil". Instead of "process oil", low-viscosity motor oil is used in the manufacture of C-4 for civilian use. The British PE4 consists of 88.0% RDX, 1.0% pentaerythrite dioleate and 11.0% DG-29 lithium grease (corresp. to 2.2% lithium stearate and 8.8% mineral oil BP) as the binder; a taggant (2,3-dimethyl-2,3-dinitrobutane, DMDNB) is added at a minimum of 0.10% weight of the plastic explosive, typically at 1.0% mass. The newer PE7 consists of 88.0% RDX, 1.0% DMDNB taggant and 11.0% of a binder composed of low molecular mass hydroxyl-terminated polybutadiene, along with an antioxidant and an agent preventing hardening of the binder upon prolonged storage. The PE8 consists of 86.5% RDX, 1.0% DMDNB taggant and 12.5% of a binder composed of di(2-ethylhexyl) sebacate thickened with high molecular mass polyisobutylene. Technical data according to the Department of the Army for the Composition C-4 follows.

=== Japan === Japanese food distribution drastically decreased from the effects of World War Two and the country's economic shortcomings. The need for food during the 1920s and 1930s rose drastically as Japan's population and average lifestyle increased. Japan was importing large amounts of rice, sugar, soybeans, and wheat from its colonies by 1935, and had a dependence on colonial possessions to distribute food to her people. 95% of Japanese rice between 1936 and 1938, just a few years before major conflict arose with the United States, was imported from its colonies in Korea and Formosa. Only 2% of Japan's rice came from foreign countries. As war engulfed Japan after 1941, food distribution efforts began to suffer. Japan lost a tremendous amount of cargo ships and was surrounded by an effective US blockade for most of the war. Imports were down, which cut off Japan from its primary source of food. Rationing programs, ran by Japan's Central Foodstuff Corporation and Local Foodstuff Corporations, were an attempt to distribute food equally among the general population. Changes in tax collection and price control were also created to feed Japan, but these measures ultimately did not supply the Japanese people with enough food for survival. The average ration allowance consisted of a flour mixture which was often unhealthy and barely edible. Normal consumers age 16 to 60 received an average 330 g of ration per day in May 1943, and the situation only became more desperate as the war progressed.

In June 1945, the squadron initially flew missions with the 310th Fighter Squadron, often twice a day, using borrowed U.S. aircraft. It received 25 new P-47D-30-RA aircraft in July, marked with the insignia of both the USAAF and Mexican Air Force. The squadron flew more than 90 combat missions, totaling more than 1,900 hours of flight time. It participated in the Allied effort to bomb Luzon and Formosa to push the Japanese out of those islands. It relentlessly attacked the Japanese forces concentrated mainly in Luzon and flew 53 combat missions as part of the U.S. Air Force warfare organization, was specified in the support of the 25th Infantry Division, the Philippine Army, as well as numerous Filipino guerrillas, to open up into the Cagayan valley where the squadron devastated the Japanese defenses on the ground with its bombs. Close support missions consisted mainly of attacking resistance points, apart from these they launched attacks on bases, fortifications, supply routes and machine gun pits. During its fighting in the Philippines, five squadron pilots died (one was shot down, one crashed, and three ran out of fuel and died at sea); and three others died in accidents during training. The pilot Héctor Espinoza Galván was flying together with an American pilot but he ran out of fuel and fell into the ocean; His body was never found. Captain Pablo Ribaz Martínez and Second Lieutenant Guillermo García Ramos were surrounded by a storm, Ribaz Martínez dying while García Ramos survived after being rescued.

== Deployments == In Côte d'Ivoire the system has been implemented across a national network of clinical laboratories as part of an HIV and public-health laboratory data programme. In 2020, the United Nations Development Programme (UNDP) country office in Mauritius acted as liaison to implement OpenELIS at the country's Central Health Laboratory during the COVID-19 pandemic; UNDP reported that the deployment reduced the staff required to process and report test data and avoided a substantially larger procurement cost. Implementations have also been reported in Kenya.

=== Cancer === Gp100 peptide vaccine is studied to treat melanoma. To generate a greater in vitro CTL response, the peptide, gp100:209-217(210M), is modified and binds to HLA-A2*0201. After vaccination, more circulating T cells can recognize and kill melanoma cancer cells in vitro. Rindopepimut is the epidermal growth factor receptor (EGFR)-derived peptide vaccine to treat glioblastoma multiforme (GBM). The 14-mer peptide is coupled with keyhole limpet hemocyanin (KLH), which can reduce the risk of cancer. E75, GP2, and AE37 are three different HER2/neu-derived single-peptide vaccines to treat breast cancer. HER2/neu usually has low expression in healthy tissues. E75 consisting of 9 amino acids is the immunodominant epitope of the HER2 protein. GP2 consisting of 9 amino acids is the subdominant epitope. Both E75 and GP2 stimulate the CD8+ lymphocytes but GP2 has a lower affinity than E75. AE37 stimulates CD4+ lymphocytes.

Sources: en.wikipedia.org

Supporting material

=== Augmentation of Tumor Necrosis Factor === Injection of tuftsin intraperitoneally increases the formulation of TNF in serum and supernatants of cultured splenic and peritoneal adherent cells. This was also demonstrated in vitro using HL60 leukemia cells.

Joseph Robinette Biden Jr. was born on November 20, 1942, at St. Mary's Hospital in Scranton, Pennsylvania, to Catherine Eugenia "Jean" Biden (née Finnegan) and Joseph Robinette Biden Sr. He is the oldest child in a Catholic family of predominantly Irish descent. Biden has a sister, Valerie, and two brothers, James and Francis. Joseph Sr. had been wealthy, and the family purchased a home in the affluent Long Island suburb of Garden City, New York, in 1946. After he suffered business setbacks around the time Biden was seven years old, the family lived with Jean's parents in Scranton for several years. Scranton fell into economic decline during the 1950s, and Joseph Sr. could not find steady work. Beginning in 1953, when Biden was ten, the family lived in an apartment in Claymont, Delaware, before moving to a house in nearby Mayfield, Delaware. Joseph Sr. later became a successful used-car salesman, maintaining the family in a middle-class lifestyle. Growing up, Biden observed alcoholism in his family, deciding at a young age to be teetotal. At Archmere Academy in Claymont, Biden played baseball and was a standout halfback and wide receiver on the high school football team. Though a poor student, he was class president in his junior and senior years. He graduated in 1961. At the University of Delaware in Newark, Biden briefly played freshman football and received a Bachelor of Arts degree with a double major in history and political science in 1965. To overcome a childhood stutter, he memorized lines from Ralph Waldo Emerson and William Butler Yeats.

Since the onset of the 21st century, Australia has found that childhood obesity has followed trend with the United States. Information garnered has concluded that the increase has occurred in lower socioeconomic areas, where poor nutritional education has been blamed.

ATSDR Case Studies in Environmental Medicine: Beryllium Toxicity Archived 2016-02-04 at the Wayback Machine U.S. Department of Health and Human Services CDC – Research on Beryllium Sensitization and Chronic Beryllium Disease – NIOSH Workplace Safety and Health Topic Beryllium Network Archived 2009-02-28 at the Wayback Machine Health-cares.net Instant insight from the Royal Society of Chemistry examining the molecular basis of chronic beryllium disease Rosner, David; Markowitz, Gerald E. (February 1987). "Ch. 7: Salem Sarcoid:The Origins of Beryllium Disease". Dying for work: workers' safety and health in twentieth-century America. Indiana University Press. pp. 103–. ISBN 978-0-253-31825-1.

Sources: en.wikipedia.org

Notes from published material

=== Effectiveness === After insertion, Mirena is effective at preventing pregnancy for up to eight years. Kyleena is approved for five years and Skyla is approved for three years. The hormonal IUD is a long-acting reversible contraceptive, and is considered one of the most effective forms of birth control. The first year failure rate for the hormonal IUD is 0.1-0.2% and the five-year failure rate is 0.7-0.9%. These rates are comparable to tubal sterilization, but unlike sterilization the effects of the hormonal IUD are reversible. The hormonal IUD is considered to be more effective than other common forms of reversible contraception, such as the birth control pill, because it requires little action by the user after insertion. The effectiveness of other forms of birth control is mitigated (decreased) by the users themselves. If medication regimens for contraception are not followed precisely, the method becomes less effective. IUDs require no daily, weekly, or monthly regimen, so their typical use failure rate is therefore the same as their perfect use failure rate. In a 10-year study, the levonorgestrel IUD was found to be as effective as oral medicines (tranexamic acid, mefenamic acid, combined oestrogen–progestogen or progesterone alone) for heavy periods; the same proportion of study participants had not had surgery for heavy bleeding and had similar improvements in their quality of life. In people with complete bicornuate uterus and in need of contraception, two IUDs are generally applied (one in each horn) due to lack of evidence of efficacy with only one IUD.

== External links == Working Principle of Spring Check Valves Check Valves Tutorial The operation, benefits, applications and selection of different designs, including lift, disc, swing and wafer check valves are explained in this tutorial A picture of a microscopic checkvalve, a scaled down version of Tesla's original fluidic diode. US Patent 1,329,559, Tesla's original fluidic diode (a test of a design showing very poor performance – n.b. the test protocol did not match the conditions described in the patent) Check Valve Installation and Benefits

The earliest reference to tomatoes being grown in British North America is from 1710, when herbalist William Salmon saw them in what is today South Carolina, perhaps introduced from the Caribbean. By the mid-18th century, they were cultivated on some Carolina plantations, and probably in other parts of the Southeast. Thomas Jefferson, who ate tomatoes in Paris, sent some seeds back to America. After 1860, it was often claimed that Americans believed that tomatoes were poisonous into the 1820s, but the belief was never widespread. When Alexander W. Livingston (1821–1898) began developing the tomato as a commercial crop, he had aimed to grow tomatoes smooth in contour, uniform in size, and sweet in flavor. He eventually developed over seventeen varieties. The U.S. Department of Agriculture's 1937 yearbook declared that "half of the major varieties were a result of the abilities of the Livingstons to evaluate and perpetuate superior material in the tomato". Livingston's first breed of tomato, the Paragon, was introduced in 1870. In 1875, he introduced the Acme, said to be in the parentage of most cultivars for the next twenty-five years. Other early breeders included Henry Tilden in Iowa and a Dr. Hand in Baltimore. Because of the tomato's need for heat and a long growing season, several states in the Sun Belt became major producers, particularly Florida and California. In California, tomatoes are grown under irrigation for both the fresh market and for canning and processing. The University of California, Davis's C.M.

== Sources == Flegel, Melinda J. (2004). Sport first aid: A coach's guide to preventing and responding to injuries. Hong Kong, Japan: Human Kinetics. Lindsay, R., Watson, G., Hickmont, D., Broadfoot, A., & Bruynel, L. (1994). Treat your own strains sprains and bruises. New Zealand: Spinal Publications. Lovering, R.M. (2008). "Physical therapy and related interventions". In P.M. Tiidus (ed.), Skeletal muscle damage and repair (pp. 219–230). United States of America: Human Kinetics. Prentice, William E. "Tissue Response to Injury", Principles of Athletic Training: A Competency Based Approach. 14th ed. New York: McGraw Hill Companies, 2011. 260–277. Subotnick, Steven (1991). Sports and Exercise Injuries: Conventional, Homeopathic and Alternative Treatments. California, United States of America: North Atlantic Books.

Committee on Armed Services Subcommittee on Cybersecurity Subcommittee on Emerging Threats and Capabilities Subcommittee on Seapower Committee on Commerce, Science, and Transportation Subcommittee on Space and Science (Ranking Member) Subcommittee on Communications, Media, and Broadband Subcommittee on Surface Transportation, Maritime, Freight, and Ports

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan II identical to alpha-melanocyte-stimulating hormone?

No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.

How does melanotan II differ from afamelanotide?

Afamelanotide is the linear analogue [Nle4-D-Phe7]-alpha-MSH, sometimes called melanotan I, while melanotan II is cyclic and carries three further substitutions. The two are distinct molecules and are not interchangeable in analytical testing.

Is the receptor binding profile well established?

Binding to the four melanocortin receptor subtypes is well documented in vitro. The relative contribution of each subtype to whole-body effects in humans is far less certain.

What is Melanotan-2 chemically?

It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.

Network